4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001193125-26-006328
President and CEO sold 43,168 shares at $7.82 ($337,574)
- President and CEO acquired 994 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Patel Sanjiv · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-31 | Grant or award : show line 1 in the form | +994 | $2.99 | $2,972 | 704,209 | D |
| 2026-01-06 | Sale : show line 2 in the form | −43,168 | $7.82 | $337,574 | 661,041 | D |
| Open-market sales · 43,168 sh · avg $7.82 · $337,574 | ||||||
Loading xslF345X05/ownership.xml…